🇺🇸 FDA

Company profile · Sponsor

United

United Therapeutics Europe Ltd

UTHR · NYSE pharma SILVER SPRING, MD, GB
Pipeline
24
Drugs
8
Patents
8

Quick answer

United (UTHR) is a pharma company. headquartered in SILVER SPRING, MD, GB. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 8 drugs, and 8 patents to this profile..

Company facts

Ticker UTHR
Exchange NYSE
Company type pharma
Headquarters SILVER SPRING, MD, GB
SEC CIK 0001082554

Pipeline (24)

Search pipeline →

  1. 0.2 mg/kg ketamine

    United

    Depression

    phase 3 small molecule terminated

    1 trial

  2. 1.0% C31G SAVVY vaginal gel

    United

    HIV Infections

    phase 3 small molecule active

    2 trials

  3. 1:1:1 Blood Transfusion Ratio

    United

    Trauma

    phase 3 mab completed

    1 trial

  4. 2 mg Melatonin

    United

    Anxiety

    phase 3 small molecule completed

    1 trial

  5. 3-dimensional conformal radiation therapy

    United

    Head and Neck Cancer

    phase 3 other active

    1 trial

  6. 4-aminopyridine

    United

    Spinal Muscular Atrophy

    phase 3 small molecule completed

    1 trial

  7. 600 mg Ibuprofen

    United

    Tibial Fractures

    phase 3 small molecule active

    1 trial

  8. ALVAC-HIV vCP1521 + AIDSVAX

    United

    HIV Infection

    phase 3 mab completed

    1 trial

  9. Abemaciclib

    United

    Breast Cancer Female

    phase 3 small molecule active

    1 trial

  10. Active CTC Assessment

    United

    Adenocarcinoma of the Prostate

    phase 3 other terminated

    1 trial

  11. Albendazole

    United

    Helminthiasis

    phase 3 small molecule completed

    1 trial

  12. Albendazole (400 mg) and/or Vitamin a

    United

    Malnutrition

    phase 3 small molecule completed

    1 trial

  13. Alemtuzumab

    United

    Kidney Transplantation

    phase 3 small molecule completed

    1 trial

  14. Alfuzosin

    United

    Kidney Stones

    phase 3 small molecule active

    1 trial

  15. Amlodipine

    United

    Depression

    phase 3 small molecule active

    1 trial

  16. Amoxycillin

    United

    Non-Severe Pneumonia With Wheeze

    phase 3 small molecule completed

    1 trial

  17. Anakinra 100mg and Placebo Depo-Medrone

    United

    Gout

    phase 3 small molecule completed

    1 trial

  18. Anastrozole

    United

    Breast Cancer

    phase 3 small molecule active

    2 trials

  19. Anodal tDCS

    United

    Stroke

    phase 3 other active

    1 trial

  20. Antiplatelet (Aspirin, Dipyridamole, clopidogrel)

    United

    Cervical Artery Dissection

    phase 3 small molecule completed

    1 trial

  21. Apixaban

    United

    Cerebral Vein Thrombosis

    phase 3 small molecule completed

    2 trials

  22. Aromatase Inhibitors

    United

    Breast Cancer

    phase 3 small molecule active

    1 trial

  23. Aspirin

    United

    Node Positive HER2 Negative Breast Cancer

    phase 3 small molecule terminated

    1 trial

  24. BCG (Tokyo 172) vaccine

    United

    Tuberculosis Infection

    phase 3 mab terminated

    1 trial

Drugs (8)

Search drugs →

  1. citric acid

    UROLOGIC G IN PLASTIC CONTAINER

    IRRIGATION approved

  2. colesevelam hydrochloride

    COLESEVELAM HYDROCHLORIDE

    ORAL approved

  3. dinutuximab

    UNITUXIN

    INTRAVENOUS approved

    L01FX06

  4. medical air

    MEDICAL AIR, USP

    INHALATION approved

  5. phentermine hydrochloride

    PHENTERMINE HYDROCHLORIDE

    ORAL approved

  6. treprostinil

    TREPROSTINIL SCIPHARM SÀRL

    INHALATION approved

    B01AC21

  7. treprostinil diolamine

    OREPAXAM

    ORAL approved

    B01AC21

  8. treprostinil sodium

    TYVASO

    INHALATION approved

Patents (8)

Search patents →

  1. US 12419873

    Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12419941

    Poultry drinking water-based vaccine delivery system and method

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12415845

    Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12410240

    Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12410259

    CD47 targeted therapies for the treatment of infectious disease

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12404317

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12397066

    Delivery of gene therapy treatments

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12398123

    Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is United?

United (UTHR) is a pharma company. headquartered in SILVER SPRING, MD, GB. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 8 drugs, and 8 patents to this profile..

What pipeline programs does United sponsor?

We track 24 ClinicalTrials.gov-linked programs for United, including 0.2 mg/kg ketamine and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does United company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.